# Allotera Therapeutics funding rounds and investors

As of 14 Oct 2026, Allotera Therapeutics has raised $115M across 1 verified round on record; latest: $115 million Series C led by Fidelity Management & Research Company, announced 27 Aug 2025.

Allotera Therapeutics develops allogeneic T-cell therapies targeted at treating various types of blood cancers like leukemia and lymphoma.

Website: https://alloteratx.com  
Headquarters: St. Louis, Missouri  
Page: https://fireround.dev/companies/alloteratx.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-08-27 | Series C | $115 million | Fidelity Management & Research Company | none named | [packgene.com](https://www.packgene.com/frontier/082725-wugen) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.